Cargando…

Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes

Aim: The level of accumulated advanced glycation end-products (AGEs) in the skin has been shown to predict the risk of complications in patients with diabetes mellitus (DM). Recently, the level of accumulated fluorescent AGEs in the skin has become measurable as skin autofluorescence (skin AF) using...

Descripción completa

Detalles Bibliográficos
Autores principales: Ninomiya, Hiroyo, Katakami, Naoto, Sato, Ihoko, Osawa, Saeko, Yamamoto, Yuichi, Takahara, Mitsuyoshi, Kawamori, Dan, Matsuoka, Taka-aki, Shimomura, Iichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249364/
https://www.ncbi.nlm.nih.gov/pubmed/29962379
http://dx.doi.org/10.5551/jat.44859
_version_ 1783372732288729088
author Ninomiya, Hiroyo
Katakami, Naoto
Sato, Ihoko
Osawa, Saeko
Yamamoto, Yuichi
Takahara, Mitsuyoshi
Kawamori, Dan
Matsuoka, Taka-aki
Shimomura, Iichiro
author_facet Ninomiya, Hiroyo
Katakami, Naoto
Sato, Ihoko
Osawa, Saeko
Yamamoto, Yuichi
Takahara, Mitsuyoshi
Kawamori, Dan
Matsuoka, Taka-aki
Shimomura, Iichiro
author_sort Ninomiya, Hiroyo
collection PubMed
description Aim: The level of accumulated advanced glycation end-products (AGEs) in the skin has been shown to predict the risk of complications in patients with diabetes mellitus (DM). Recently, the level of accumulated fluorescent AGEs in the skin has become measurable as skin autofluorescence (skin AF) using a non-invasive apparatus, autofluorescence reader. The purpose of this study was to evaluate the association between skin AF and the subclinical atherosclerosis markers, especially endothelial dysfunction, in patients with DM. Methods: We enrolled 140 Japanese subjects with DM who attended Osaka University Hospital, and measured the skin level of AGEs by skin AF and three subclinical atherosclerosis markers: endothelial function by flow-mediated vasodilation, FMD; carotid intima-media thickness, IMT; and brachial-ankle pulse wave velocity, baPWV. Results: FMD was significantly associated with skin AF (r = −0.259, p = 0.002). Furthermore, a stepwise multivariate regression analysis revealed that skin AF was an independent determinant of FMD (β = −0.180, p = 0.038). Although there were significant associations between skin AF and maximum carotid intima-media thickness (max-IMT)(r = 0.298, p < 0.001) as well as baPWV (r = 0.284, p = 0.001) in univariate analysis, skin AF was not an independent determinant of either carotid max-IMT or baPWV after adjustment for conventional cardiovascular risk factors. Receiver-operating characteristic curve analysis revealed that skin AF can identify the subjects whose FMD, max-IMT, and baPWV were completely within the normal range (C-statistics, 0.73; 95% confidence interval, 0.61–0.84; p < 0.001). Conclusions: Skin AF was independently associated with FMD as an indicator of endothelial dysfunction, and can be utilized as a screening marker of atherosclerosis in Japanese patients with DM.
format Online
Article
Text
id pubmed-6249364
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Japan Atherosclerosis Society
record_format MEDLINE/PubMed
spelling pubmed-62493642018-12-01 Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes Ninomiya, Hiroyo Katakami, Naoto Sato, Ihoko Osawa, Saeko Yamamoto, Yuichi Takahara, Mitsuyoshi Kawamori, Dan Matsuoka, Taka-aki Shimomura, Iichiro J Atheroscler Thromb Original Article Aim: The level of accumulated advanced glycation end-products (AGEs) in the skin has been shown to predict the risk of complications in patients with diabetes mellitus (DM). Recently, the level of accumulated fluorescent AGEs in the skin has become measurable as skin autofluorescence (skin AF) using a non-invasive apparatus, autofluorescence reader. The purpose of this study was to evaluate the association between skin AF and the subclinical atherosclerosis markers, especially endothelial dysfunction, in patients with DM. Methods: We enrolled 140 Japanese subjects with DM who attended Osaka University Hospital, and measured the skin level of AGEs by skin AF and three subclinical atherosclerosis markers: endothelial function by flow-mediated vasodilation, FMD; carotid intima-media thickness, IMT; and brachial-ankle pulse wave velocity, baPWV. Results: FMD was significantly associated with skin AF (r = −0.259, p = 0.002). Furthermore, a stepwise multivariate regression analysis revealed that skin AF was an independent determinant of FMD (β = −0.180, p = 0.038). Although there were significant associations between skin AF and maximum carotid intima-media thickness (max-IMT)(r = 0.298, p < 0.001) as well as baPWV (r = 0.284, p = 0.001) in univariate analysis, skin AF was not an independent determinant of either carotid max-IMT or baPWV after adjustment for conventional cardiovascular risk factors. Receiver-operating characteristic curve analysis revealed that skin AF can identify the subjects whose FMD, max-IMT, and baPWV were completely within the normal range (C-statistics, 0.73; 95% confidence interval, 0.61–0.84; p < 0.001). Conclusions: Skin AF was independently associated with FMD as an indicator of endothelial dysfunction, and can be utilized as a screening marker of atherosclerosis in Japanese patients with DM. Japan Atherosclerosis Society 2018-12-01 /pmc/articles/PMC6249364/ /pubmed/29962379 http://dx.doi.org/10.5551/jat.44859 Text en 2018 Japan Atherosclerosis Society This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Original Article
Ninomiya, Hiroyo
Katakami, Naoto
Sato, Ihoko
Osawa, Saeko
Yamamoto, Yuichi
Takahara, Mitsuyoshi
Kawamori, Dan
Matsuoka, Taka-aki
Shimomura, Iichiro
Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes
title Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes
title_full Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes
title_fullStr Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes
title_full_unstemmed Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes
title_short Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes
title_sort association between subclinical atherosclerosis markers and the level of accumulated advanced glycation end-products in the skin of patients with diabetes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249364/
https://www.ncbi.nlm.nih.gov/pubmed/29962379
http://dx.doi.org/10.5551/jat.44859
work_keys_str_mv AT ninomiyahiroyo associationbetweensubclinicalatherosclerosismarkersandthelevelofaccumulatedadvancedglycationendproductsintheskinofpatientswithdiabetes
AT katakaminaoto associationbetweensubclinicalatherosclerosismarkersandthelevelofaccumulatedadvancedglycationendproductsintheskinofpatientswithdiabetes
AT satoihoko associationbetweensubclinicalatherosclerosismarkersandthelevelofaccumulatedadvancedglycationendproductsintheskinofpatientswithdiabetes
AT osawasaeko associationbetweensubclinicalatherosclerosismarkersandthelevelofaccumulatedadvancedglycationendproductsintheskinofpatientswithdiabetes
AT yamamotoyuichi associationbetweensubclinicalatherosclerosismarkersandthelevelofaccumulatedadvancedglycationendproductsintheskinofpatientswithdiabetes
AT takaharamitsuyoshi associationbetweensubclinicalatherosclerosismarkersandthelevelofaccumulatedadvancedglycationendproductsintheskinofpatientswithdiabetes
AT kawamoridan associationbetweensubclinicalatherosclerosismarkersandthelevelofaccumulatedadvancedglycationendproductsintheskinofpatientswithdiabetes
AT matsuokatakaaki associationbetweensubclinicalatherosclerosismarkersandthelevelofaccumulatedadvancedglycationendproductsintheskinofpatientswithdiabetes
AT shimomuraiichiro associationbetweensubclinicalatherosclerosismarkersandthelevelofaccumulatedadvancedglycationendproductsintheskinofpatientswithdiabetes